TPT1/ TCTP-regulated pathways in phenotypic reprogramming

Trends Cell Biol. 2013 Jan;23(1):37-46. doi: 10.1016/j.tcb.2012.10.002. Epub 2012 Oct 30.

Abstract

Evolutionary conserved and pleiotropic, the TPT1/TCTP gene (translationally controlled tumor protein, also called HRF, fortilin), encodes a highly structured mRNA shielded by ribonucleoproteins and closely resembling viral particles. This mRNA activates, as do viruses, protein kinase R (PKR). The TPT1/TCTP protein is structurally similar to mRNA-helicases and MSS4. TPT1/TCTP has recently been identified as a prognostic factor in breast cancer and a critical regulator of the tumor suppressor p53 and of the cancer stem cell (SC) compartment. Emerging evidence indicates that TPT1/TCTP is key to phenotypic reprogramming, as shown in the process of tumor reversion and possibly in pluripotency. We provide here an overview of these diverse functions of TPT1/TCTP.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor* / genetics
  • Biomarkers, Tumor* / metabolism
  • Genetic Pleiotropy*
  • Humans
  • Neoplastic Stem Cells
  • RNA, Messenger / genetics*
  • Ribonucleoproteins / genetics
  • Ribonucleoproteins / metabolism
  • Tumor Protein, Translationally-Controlled 1
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / metabolism

Substances

  • Biomarkers, Tumor
  • RNA, Messenger
  • Ribonucleoproteins
  • TPT1 protein, human
  • Tumor Protein, Translationally-Controlled 1
  • Tumor Suppressor Protein p53
  • eIF-2 Kinase